M. Charlton

Epidemiology · 2011–2018

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 132 citations into it

Whom M. Charlton trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Z. Younossi

Who trusts M. Charlton overall

1. Z. Younossi
2. R. Loomba
3. Christopher D. Byrne

Papers from M. Charlton's perspective

Ordered by how strongly the researchers M. Charlton trusts endorse each paper. Same corpus, a different order for every researcher.

1. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
2. ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (Hepatology)
3. Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality (Hepatology)
4. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. (Gastroenterology)
5. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the… (American Journal of Gastroenterology)
6. Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
7. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity (Annals medicus)
8. Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease (Hepatology)
9. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. (New England Journal of Medicine)
10. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients (Hepatology)

Their papers

• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018) — 6,253 citations
• Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease. (2015) — 854 citations
• The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2012) — 2,216 citations
• The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. (2012) — 1,723 citations
• Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (2011) — 1,087 citations